Juno Therapeutics, Inc., A Bristol-myers Squibb Company

This study was designed to see if a cell therapy called Liso-cel works better than standard treatments for adults with follicular lymphoma that has returned or not responded to prior therapy. The trial planned to enroll people with measurable disease and good physical function. H…